On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Peptidase Inhibition and Analysis

TopicLeading institutions, researchers & key papers

Peptidase Inhibition and Analysis is a topic indexed in ScholarIQ from OpenAlex.

What is known about Peptidase Inhibition and Analysis?

ScholarIQrecord summary

This cluster of papers explores the role of fibroblast activation in cancer progression, focusing on the expression of fibroblast activation protein, immunosuppression in the tumor microenvironment, N-terminal acetylation of proteins, protease inhibitors for cancer therapy, angiogenesis, and PET imaging to target stromal cells in the tumor microenvironment.

How many works does Peptidase Inhibition and Analysis have?

ScholarIQindexed works

Peptidase Inhibition and Analysis has 278 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Peptidase Inhibition and Analysis?

ScholarIQopenalex

The OpenAlex for Peptidase Inhibition and Analysis is on the source record.

What are the most-cited papers on Peptidase Inhibition and Analysis?

ScholarIQmost cited works
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Dooseop Kim, Liping Wang, Maria Beconi, George J. Eiermann, Michael H. Fisher, Huaibing He, Gerard J. Hickey, Jennifer E. Kowalchick, Barbara Leiting, Kathryn A. Lyons, Frank Marsilio, Margaret E. McCann, Reshma A. Patel, Aleksandr Petrov, Giovanna Scapin, Sangita B. Patel, Ranabir Sinha Roy, Joseph K. Wu, Matthew J. Wyvratt, Bei B. Zhang, Lan Zhu, Nancy A. Thornberry, Ann E. Weber
Journal of Medicinal Chemistry. 2004818 CitationsOPEN ACCESS
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu, Yawei Hu, Qihui Wang, Jianxun Qi, Feng Gao, Yan Li, Yanfang Zhang, Wei Zhang, Yuan Yuan, Jinku Bao, Buchang Zhang, Yi Shi, Jinghua Yan, George F. Gao
Nature. 2013763 CitationsOPEN ACCESS
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
Masanori Asakura, Masafumi Kitakaze, Seiji Takashima, Yulin Liao, Fuminobu Ishikura, Tsuyoshi Yoshinaka, Hiroshi Ohmoto, Koichi Node, Kohichiro Yoshino, Hiroshi Ishiguro, Hiroshi Asanuma, Shoji Sanada, Yasushi Matsumura, Hiroshi Takeda, Shintaro Beppu, Michihiko Tada, Masatsugu Hori, Shigeki Higashiyama
Nature Medicine. 2002722 Citations
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
Haojun Chen, Yizhen Pang, Jingxun Wu, Liang Zhao, Bing Hao, Jing Wu, Jihong Wei, Siming Wu, Long Zhao, Zuoming Luo, Xuehua Lin, Chengrong Xie, Long Sun, Qin Lin, Hua Wu
European Journal of Nuclear Medicine and Molecular Imaging. 2020548 Citations
The moonlighting enzyme CD13: old and new functions to target
Paola Mina‐Osorio
Trends in Molecular Medicine. 2008410 CitationsOPEN ACCESS

Where is Peptidase Inhibition and Analysis research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Peptidase Inhibition and Analysis is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
7%
Green
27%
Hybrid
13%
Bronze
27%
Closed
27%

Related on ScholarIQ

470M+ articles · 14-day free trial